RNA Therapies
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
112
NCT06205524
A Study to Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults
Phase: Phase 1
Role: Collaborator
Start: Jul 10, 2023
Completion: Feb 1, 2025
NCT07081984
Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors
Role: Lead Sponsor
Start: Sep 1, 2025
Completion: Jul 31, 2027
Loading map...